DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $469,000 | +35.9% | 12,575 | -6.9% | 0.00% | 0.0% |
| Q1 2021 | $345,000 | +18.6% | 13,513 | +1.7% | 0.00% | 0.0% |
| Q4 2020 | $291,000 | +35.3% | 13,290 | +10.8% | 0.00% | +100.0% |
| Q3 2020 | $215,000 | -6.5% | 11,990 | +32.0% | 0.00% | 0.0% |
| Q2 2020 | $230,000 | +52.3% | 9,085 | +32.5% | 0.00% | 0.0% |
| Q1 2020 | $151,000 | 0.0% | 6,855 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $151,000 | – | 6,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |